0001104659-14-034700.txt : 20140505
0001104659-14-034700.hdr.sgml : 20140505
20140505174432
ACCESSION NUMBER: 0001104659-14-034700
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140427
FILED AS OF DATE: 20140505
DATE AS OF CHANGE: 20140505
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INCYTE CORP
CENTRAL INDEX KEY: 0000879169
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
IRS NUMBER: 943136539
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ROUTE 141 & HENRY CLAY ROAD
STREET 2: BUILDING E336
CITY: WILMINGTON
STATE: DE
ZIP: 19880
BUSINESS PHONE: 3024986700
MAIL ADDRESS:
STREET 1: ROUTE 141 & HENRY CLAY ROAD
STREET 2: BUILDING E336
CITY: WILMINGTON
STATE: DE
ZIP: 19880
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE CORP
DATE OF NAME CHANGE: 20030318
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE GENOMICS INC
DATE OF NAME CHANGE: 20000710
FORMER COMPANY:
FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19930902
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Huber Reid M
CENTRAL INDEX KEY: 0001607052
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12400
FILM NUMBER: 14814757
MAIL ADDRESS:
STREET 1: C/O INCYTE CORPORATION, EXPERIMENTAL STN
STREET 2: ROUTE 141 & HENRY CLAY ROAD, BLDG. E336
CITY: WILMINGTON
STATE: DE
ZIP: 19880
3
1
a3.xml
3
X0206
3
2014-04-27
0
0000879169
INCYTE CORP
INCY
0001607052
Huber Reid M
EXPERIMENTAL STATION,
ROUTE 141 & HENRY CLAY ROAD
WILMINGTON
DE
19880
0
1
0
0
Exec VP & Chief Scientific Off
Common Stock
16932
D
Incentive Stock Option (right to buy)
5.46
2016-01-12
Common Stock
2900
D
Incentive Stock Option (right to buy)
3.11
2016-01-26
Common Stock
7225
D
Incentive Stock Option (right to buy)
9.41
2017-01-20
Common Stock
14329
D
Incentive Stock Option (right to buy)
13.34
2017-05-17
Common Stock
1355
D
Incentive Stock Option (right to buy)
14.72
2018-01-24
Common Stock
8030
D
Incentive Stock Option (right to buy)
17.79
2019-01-18
Common Stock
6991
D
Non-Qualified Stock Option (right to buy)
17.79
2019-01-18
Common Stock
16764
D
Incentive Stock Option (right to buy)
18.32
2020-02-08
Common Stock
7458
D
Non-Qualified Stock Option (right to buy)
18.32
2020-02-08
Common Stock
39208
D
Incentive Stock Option (right to buy)
64.55
2021-01-20
Common Stock
1059
D
Non-Qualified Stock Option (right to buy)
64.55
2021-01-20
Common Stock
21011
D
Includes 16,309 shares underlying restricted stock units ("RSUs") that will vest in full on April 8, 2017, subject to Dr. Huber's continued service with the Issuer through such vesting date. The RSUs may be settled only for shares of common stock on a one-for-one basis.
Beginning January 13, 2006, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.
Beginning January 27, 2009, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
Beginning January 21, 2010, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
Beginning May 18, 2010, options become exercisable in 25 installments, with the first 33.33% vesting January 21, 2011 and the remainder vesting monthly through January 21, 2013.
Beginning January 25, 2011, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
Beginning January 19, 2012, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
Beginning February 9, 2013, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
Beginning January 21, 2014, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years.
/s/ Eric H. Siegel , Attorney-in-Fact
2014-05-05